Actions of glucagon-like peptide-1 on KATP channel-dependent and -independent effects of glucose, sulphonylureas and nateglinide

Journal of Endocrinology

Volumn 190, Issue 3, 2006, Pages 889-896

  McClenaghan, Neville H ^a   Flatt, Peter R ^a   Ball, Andrew J ^a,b  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b MILLIPORE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLIBENCLAMIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOSE; INSULIN; NATEGLINIDE; POTASSIUM CHANNEL; PROTEIN KINASE C; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

ANIMAL CELL; ARTICLE; CELL POLARITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOHEXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; PHENYLALANINE; POTASSIUM CHANNELS; PROTEIN KINASE C; STIMULATION, CHEMICAL; SULFONYLUREA COMPOUNDS; TETRADECANOYLPHORBOL ACETATE;

EID: 33749852796     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06949     Document Type: Article

References (36)

1. + channels and insulin secretion: their role in health and disease. Diabetologia 42 903-919.
2. Ball AJ, McCluskey JT, Flatt PR & McClenaghan NH 2000a Drug-induced desensitization of insulinotropic actions of sulfonylureas. Biochemical and Biophysical Research Communications 271 234-239.
3. Ball AJ, Flatt PR & McClenaghan N-H 2000b Desensitization of sulphonylurea- and nutrient-induced insulin secretion following prolonged treatment with glibenclamide. European Journal of Pharmacology 408 327-333.
4. Ball AJ, McCluskey JT, Flatt PR & McClenaghan NH 2004a Chronic exposure to tolbutamide and glibenclamide impairs insulin secretion but not transcription of K(ATP) channel components. Pharmacology Research 50 41-46.
5. Ball AJ, Flatt PR & McClenaghan NH 2004b Acute and long-term effects of nateglinide on insulin secretory pathways. British Journal of Pharmacology 142 367-373.
6. Ball AJ, Flatt PR & McClenaghan NH 2005 Alterations of insulin secretion following long-term manipulation of ATP-sensitive potassium channels by diazoxide and nateglinide. Biochemical Pharmacology 69 59-63.
7. Brennan L, Shine A, Hewage C, Malthouse JPG, Brindle KM, McClenaghan NH, Flatt PR & Newsholme, P 2002 A NMR based demonstration of substantial oxidative L-alanine metabolism and L-alanine enhanced glucose metabolism in a clonal pancreatic beta cell line - metabolism of L-alanine is important to the regulation of insulin secretion. Diabetes 51 1714-1721.
8. Bryan J, Crane A, Vila-Carriles WH, Babenko, AP & Aguilar-Bryan L 2005 Insulin secretagogues, sulfonylurea receptors and K(ATP) channels. Current Pharmaceutical Design 11 2699-2716.
9. Chapman JC, McClenaghan NH, Cosgrove KE, Hashmi MN, Shepherd RM, Giesberts AN, White SJ, Ammala C, Flatt PR & Dunne MJ 1999 ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line. Diabetes 48 2349-2357.
10. Drucker DJ 2003 Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care 26 2929-2940.
11. Egan JM, Bulotta A, Hui H & Perfetti R 2003 GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells. Diabetes Metabolism Research and Reviews 19 115-123.
12. Eliasson L, Renström E, Ämmälä C, Berggren P-O, Bertorello AM, Bokvist K, Chibalin A, Deeney JT, Flatt PR, Gäbel J et al. 1996 PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic β-cells. Science 271 813-815.
13. Eliasson L, Ma X, Renstrom E, Barg S, Berggren PO, Galvanovskis J, Gromada J, Jing X, Lundquist I, Salehi A et al. 2003 SUR1 regulates PKA-independent cAMP-induced granule priming in mouse pancreatic β-cells. Journal of General Physiology 121 181-197.
14. Flatt PR, Shibier O, Szecowka J & Berggren PO 1994 New perspectives on the actions of sulphonylureas and hyperglycamic sulphonamides on the pancreatic β-cell. Diabete and Metabolisme 20 157-162.
15. Green BD, Gault VA, O'Harte FP & Flatt PK 2004 Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents. Current Pharmaceutical Design 10 3651-3662.
16. Gromada J, Dissing S & Rorsman P 1996 Desensitization of glucagon-like peptide 1 receptors in insulin-secreting beta TC3 cells: role of PKA-independent mechanisms. British Journal of Pharmacology 118 769-775.
17. Gromada J, Bokvist K, Ding WG, Holst JJ, Nielsen JH & Rorsman P 1998 Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling. Diabetes 47 57-65.
18. Gromada J, Brock B, Schmitz O & Rorsman P 2004 Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential. Basic Clinical Pharmacology and Toxicology 95 252-262.
19. Gutniak MK, Juntti-Berggren L, Hellstrom PM, Guenifi A, Holst JJ & Efendic S 1996 Glucagon-like peptide I enhances die insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. Diabetes Care 19 857-863.
20. Hansen AM, Christensen IT, Hansen JB, Carr RD, Ashcroft FM & Wahl P 2002 Differential interactions of nateglinide and repaglinide on the human beta-cell sulphonylurea receptor 1. Diabetes 51 2789-2795.
21. Henquin JC 2000 Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49 1751-1760.
22. Holst JJ 2002 Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1. Diabetes Metabolism Research and Reviews 18 430-441.
23. Hu S 2002 Interaction of nateglinide with K(ATP) channel in beta-cells underlies its unique insulinotropic action. European Journal of Pharmacology 442 163-171.
24. Kamp F, Kizilbash N, Corkey BE, Berggren PO & Hamilton JR, 2003 Sulfonylureas rapidly cross phospholipids bilayer membranes by a free diffusion mechanism. Diabetes 32 2526-2531.
25. Krentz AJ & Bailey CJ 2005 Oral and diabetic agents: current role in type 2 diabetes mellitus. Drugs 65 385-411.
26. McClenaghan NH, Barnett CR, Ah-Sing E, Abdel-Wahab YH, O'Harte FP, Yoon TW, Swanston-Flatt SK & Flatt PR 1996 Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion. Diabetes 45 1132-1140.
27. MacDonald PE, El-Kholy W, Riedel MJ, Salapatek AM, Light PE & Wheeler MB 2002 The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes 51 S434-S442.
28. Matthews DR, Cull CA, Stratton IM, Holman RR & Turner RC 1998 UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years. Diabetic Medicine 15 297-303.
29. Nakazaki M, Crane A, Hu M, Seghers V, Ullrich S, Aguilar-Bryan L & Bryan J 2002 cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets. Diabetes 51 3440-3449.
30. Rabuazzo AM, Buscema M, Vinci C, Caltabiano V, Vetri M, Forte F, Vigneri R & Purrello F 1992 Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms. Endocrinology 13 1815-1820.
31. Renstrom E, Eliasson L & Rorsman P 1997 Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic β-cells. Journal of Physiology 502 105-118.
32. Renstrom E, Barg S, Thevenod F & Rorsman P 2002 Sulfonylurea-mediated stimulation of insulin exocytosis via an ATP-sensidve K+ channel-independent action. Diabetes 51 S33-S36.
33. 2+ signalling in single clonal insulin-secreting cells: evidence for a mixed model of cellular activation. International Journal of Biochemistry and Cell Biology 32 557-569.
34. 2+ and exocytosis in pancreatic beta-cells. Pflugers Archiv: European Journal of Physiology 437 577-588.
35. Tian Y-M, Johnson G & Ashcroft SJH 1998 Sulfonylureas stimulate exoxytosis from pancreatic β-cells by a mechanism that does not involve direct activation of protein kinase C. Diabetes 47 1722-1726.
36. 2+ oscillations in insulin-producing BRIN-BD11 cells. Diabetes 51 366-375.